0000899243-21-039956.txt : 20211012 0000899243-21-039956.hdr.sgml : 20211012 20211012202002 ACCESSION NUMBER: 0000899243-21-039956 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211008 FILED AS OF DATE: 20211012 DATE AS OF CHANGE: 20211012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stacey Jennifer Evans CENTRAL INDEX KEY: 0001321326 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 211319871 MAIL ADDRESS: STREET 1: AUXILIUM PHARMACEUTICALS, INC. STREET 2: 160 WEST GERMANTOWN PIKE CITY: NORRISTOWN STATE: PA ZIP: 19401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-08 0 0001563577 Galera Therapeutics, Inc. GRTX 0001321326 Stacey Jennifer Evans C/O GALERA THERAPEUTICS, INC., 2 W LIBERTY BLVD #100 MALVERN PA 19355 0 1 0 0 See Remarks Stock Option (Right to Buy) 7.84 2021-10-08 4 A 0 130000 0.00 A 2031-10-07 Common Stock 130000 130000 D The option vests and becomes exercisable as to 25% on October 8, 2022, and in thirty-six (36) substantially equal monthly installments over a three year period thereafter. Chief Legal and Compliance Officer /s/ J. Mel Sorensen, Attorney-in-Fact for Jennifer Evans Stacey 2021-10-12